Welcome to our three months Q1 presentation for this fiscal year. We will begin with interim highlights by me, and then Jessica will take over and take the financial development. I will briefly mention Sectra going forward, and then we have a Q&A session, which is a little bit different this time as everyone can ask things online. We will come back to that when we come to that session. Our business operation, for those who are new to us, most of you are probably not, but just in case, our biggest business is Imaging IT, which handles images in hospitals. All medical images are handled by us if customers want it, but mainly it is radiology. Radiology is the clear dominant part of all of our Imaging IT, and Imaging IT is the dominant part of Sectra. Then the second-largest is Secure Communications, which was actually Sectra's origin. Sectra stands for secure transmission. That is encryption and systems for transfer of highly confidential data on the national security levels. Then we have Business Innovation, which is our greenhouse for future successes or sometimes we have to close them down. A little more Business Innovation products is to be either become a business line, it can be sometimes be sold off, or sometimes we close them down if we do not see success coming. Coming back to this, we have Medical Education IT, which is an interesting area of medical professionals live also in a rapidly changing world, and they need continued education. We started that area mainly for education of medical doctors in medical school, et cetera. It is increasingly for education of all partitioning doctors in the field. We recently got a contract for all of Norway, where we are to supply all of Norway radiology and pathology, continued education from a cloud platform. It is a pure cloud environment. We have Orthopaedics IT, which provides special tools based on images for orthopedicians planning surgery and follow-up after surgery. We have our new area, Genomics IT, which is about the DNA and modern medicine, especially oncology, is very much about gene sequencing, but it has not been reproduction. We have production systems where production, especially is for medical. So this is not images, but it is closely related to images, so we do that in Genomics IT. Then we have research part, mainly doing AI research in Sectra Communication. We also have a growth area in critical infrastructure, security for critical infrastructure. In Imaging IT, we have one area that we moved from the Business Innovation group into Imaging IT about 10 years ago for digital pathology. We add that to radiology. A new area is outputs. All diagnostics must result in a result, and that is documented in a report. That report needs to be efficient, needs to be tightly integrated with imaging components, especially in radiology. That has been dominated by other companies before, especially in the U.S. But we are now creating tools where you can sit and interact with the report based also a lot of AI there to create very efficient diagnostic reporting directly when interacting with him. Highlights from the quarter. Our contract order bookings went down, but we had an exceptional first quarter last year. Our contracts are now very large and very long in time, therefore, we are not overly concerned about that. The book-to-bill ratio of 12 months is still very healthy. Net sales rose by 26%, profit per share rose by 55%. We are transforming into a Software as a Service model. Instead of paying up front as customers did before for big license sales, they pay us now while they use the product. That means delayed time or longer time till we begin to get revenue from order, but also much longer revenue stream long-term. Long-term, this is very beneficial for both customers and vendors as we talk. The cloud recurring revenue is the part of recurring revenue that we deliver over the cloud, that predominantly is in the U.S., Canada, U.K., but also to some extent is Europe. That rose by 75%, is now beginning to be a significant part of our revenues. Recurring revenue in general, which includes the cloud recurring revenue as a part, rose by 32%. That includes normal service contracts and a few other things as well. The churn, the return revenue that we lost, which is a very important factor. If you have customers who pay you for usage, you don't want them to stop using your system. The churn was 0.5%, which is a very good figure. We don't lose many customers. We lose some, but not many. The financial targets for the groups, stability, equity, assets ratio. We sell critical systems both in cybersecurity and in medicine. If our systems fail, the hospitals come to a grinding halt. Imaging is a critical part of modern healthcare. The customers do not want to buy that from an unstable company. It's dangerous. So being a stable company, financially solid, is important. We have an equity assets ratio of 30% target. We are ways above that at 52%. Profitability, which is a second. These are prioritized in the order one, two, three here. The second highest prioritized target is profitability. Operating margin, that should be above 15%. We're well above that at 21%. Both of these are hygiene measures. The most important figure, but after the first two are fulfilled, is growth of profits per share. So EBIT per share growth over a five-year period should be 50% or better. We are currently ways above that at 90% growth. In Imaging IT Solutions, our largest area, headed by Marie Ekström Trägårdh. We are leading that cloud transition. We have large contracts that we have published over the last two, three years. They are now in rollout mode. We are rolling out, we are installing a hospital a week or something like that. Some of these contracts are very many hospitals in one single contract. So the deployments go over seven years. Two health boards in Scotland. Scotland was one of those large. Two health boards are now live, then new ones are added all the time. In the U.S. and Canada, we have very large contracts, both in Québec, which is public, some other operators in the U.S., which we are not allowed to disclose who they are, but they are very large. These are all now in delivery mode. All of the big contracts are in delivery, and we add a few every month, or we are adding many every month, I would say. We also have a large interest with diagnostic reporting that I mentioned before. The output of diagnostic is a report, and that should include images and be very efficient to produce, and it contains a lot of AI in making them as well. We are revamping that and releasing a new diagnostic reporting system, initially offered mainly in the U.S., but we have large interest all over the world. That is a significant part of regular business that is up for grabs if you can do it. But there are other competitors there than we normally see. In Sectra Communications, we are supporting national resilience and total defense preparedness. Of course, these are now the crisis in Europe with Ukraine. The interest and growth has gone up in that area a lot. We had production problems in Q1 that meant a factory came to a grinding halt for a while. That is now resolved. We have begun deliveries again, but that impacted Q1 a lot for communications. That is now resolved. Of course, the crisis in Europe drives demand. In general, cybersecurity is a rapidly growing area, not the least with AI, that I will come back to later. I will leave the word to Jessica, who will go into the financials a little more. Thank you. Good morning, and thank you for joining our call today. We are reporting a first quarter of strong growth in recurring revenue and in operating profit. Before I walk you through the financial development, I would like to highlight a few changes that we have made to the format of our interim report. First, to improve readability, starting this quarter, we report amounts in millions without decimals, unless otherwise stated. Secondly, we have added external sales by segment, and we have expanded the table in note six to reflect this change. Thirdly, we have expanded the income statements by quarter, and we have added cash flow statements by quarter. We hope that these changes will add value to the readers of the reports. Order intake. We reported SEK 699 million of contracted order bookings in the first quarter, a decrease of 47% year-over-year. Despite the lower figure, demand for our solutions remains high in all operating areas. As you heard Torbjörn say, given the long-term nature of our contracts, we expect quarterly order intake to continue to fluctuate significantly going forward. The rolling 12 book-to-bill ratio is at 1.9. We did not sign any individually large orders this quarter, but we saw increased order intake in Australia, Norway, Germany, and Portugal. Our net sales in the first quarter amounted to SEK 963 million, corresponding to an increase of 26% year-over-year. The continued growth of usage or use of our services is driving the recurring revenue growth up 32% year-over-year. We also saw non-recurring revenue increase year-over-year by 11%, mainly from license revenue, migration, and professional services delivered during the quarter. Our cloud recurring revenue keeps growing. We increased by 75% to SEK 315 million, and for the first time, we saw rolling 12 that the cloud recurring revenue is exceeding SEK 1 billion. Currency movements had a small negative impact on sales in the quarter, and the pattern for recurring revenue churn is unchanged. Please note that the chart on this slide shows the changes in external sales, whereas in previous reports and presentations, we have included internal sales as well. Imaging IT increased sales by 30% year-over-year, and the main driver is volume, increased usage of services, and additional deployments of new sites. The share recurring revenue in this area is high. It was close to 78% in the quarter. Sales in Secure Communications decreased by 4% to SEK 89 million year-over-year, following continued impact from the delays in delivery. In Business Innovation, sales primarily go through the Sectra One service in Imaging IT. As a result of that, we will see limited external sales reported for Business Innovation. Looking at our geographic markets, the U.S. reported the by far largest increase in sales. All other markets contributed to growth, except the U.K., where we saw temporary decline year-over-year. Our operating profit increased significantly year-over-year by 61% to SEK 191 million. The operating margin improved to 19.8%, compared with the 15.5% driven by the development in Imaging IT. Profit was held back by Secure Communications performance in the first quarter and also partly by currency headwind. Operating profit variations have leveled out over the past four quarters, which is according to expectations, transitioning to become a service provider. With large individual contracts and also on-prem deliveries, there may still be quarters deviating from this trend. Imaging IT increased the profit by 77% year-over-year, and the margin reached 23%. Again, the driver in this area is volume. More medical images through increased usage and also additional deployments and add-on sales. We also note that the rapid growth in this area requires investments. Investments to further scale and refine our offerings, our organization, and also our ways of working, while at the same time maintaining a strong focus on quality and security. Secure Communications reported an operating profit slightly above break even. Serial production started end of last fiscal year, but as already commented, it was on a small scale in Q1. Our cash flow from operations amounted to SEK 3 million in the first quarter, compared with SEK 118 million in the corresponding quarter last year. Our underlying performance has improved, but the changes in working capital had a negative impact on cash flow, mainly temporary timing effects between quarters. We ended the reporting period with a cash balance of SEK 1.8 billion. Based on our strong financial position, the board and CEO proposed a total dividend of SEK 443 million to the shareholders, and for approval at next week's annual general meeting. That was my last slide. All right. Thank you, Jessica. Going forward, I spoke last time about the AI wave. We have a tremendous wave of AI coming all over, and it has not slowed down. It is rather faster than before. The AI wave comes, so we can like it or dislike it, cannot do much about it. We can choose as individuals and companies to either surf on the front side, trying to keep the balance, and if you fall, you rise up and try surfing again. Or you can paddle like a crazy man on the backside and try to keep up, and that would be very difficult. We have chosen the previous. We are surfing the front side. It is fast-moving. There have been huge changes just over the summer in the AI world, not the least in cybersecurity. Many of you might have heard about Mythos and things coming out, where large vulnerabilities in cyber systems or IT systems all over the world have been discovered that in some cases have been 30 years old, no one have seen them. That, of course, means that we as IT companies, all of us, all over the world, have to patch things and fix holes that we discover. We are not different from others. We will spend a lot of effort now to fixing cybersecurity issues in the products, as all IT companies do. That means we will develop a little slower, but so is the case for everyone. We are to help our customers to benefit from AI as well, in healthcare as well, in cyber resilience and defense, and we are getting quite good at it. We can provide a lot of advice and help into healthcare as well as in cyber. We also see it increasing internal efficiencies. In the beginning, people speak most about coding, but writing software is today to a very large extent done by AI. We see it all over. AI is changing the way we operate, and we are becoming more efficient. So is everyone else. It is a race here to be faster than the other ones. In medical IT, we have said many times, our main areas and the growth areas of medical IT is, or medical at large, is the age-related diseases. That is where society have to act because those are the ones who grow the most. Neurological diseases, neurodegenerative diseases, MS, Parkinson's, Alzheimer. These are very expensive and needs to be handled by society. Cardiovascular disease, cancer disease. Cancer is transforming from being an acute deadly disease 50 years ago, to now a chronic disease. People can live with multiple metastatic cancers and continue living, but they need a lot of diagnosis and healthcare while continuing their life. This drives the growth of healthcare at large. Musculoskeletal disease, a grossly undervalued area, affecting mainly women, but also men. But women very often after menopause have osteoporosis, which results in a lot of musculoskeletal problems that we are good at handling and planning and following up for. And vision. Vision is also an age-related disease that is very expensive to society and insurance companies. These are the main drivers for future needs in healthcare, and we will be there with image-related diagnostics and of course now also genomics. We are bundling all of these in one service called Sectra One. A customer can sign a contract with us, and they can do all of these if they use cardiology or ophthalmology or radiology. They just have a tick, and they get that on the next invoice. They only want to use it, not just for having access to it. We are adding reporting into that as well. We have had reporting in Europe for a long time, but we are adding reporting as a service into this, especially in the U.S. and Canada, where the need is the largest right now. We see ourselves a little like Microsoft Office in medical imaging-based diagnostics. We do not only have Word or Excel or PowerPoint. We have all of those in one subscription. We are the only one who have all of these in one single system. Radiology, cardiology, pathology, genomics, ophthalmology in one single system. The output, all of that, will go into diagnostic report. Right now, we do radiology reporting primarily. In the long term, there will be a diagnostic report that the clinician can get what is the problem with this patient. In cybersecurity, there has been a lot of events in cybersecurity and AI. Agentic AI broke out of OpenAI recently and broke into another company, despite that the environment where they tried out this new AI was sandboxed. There are very interesting videos on YouTube how that worked, but it is clear that AI will play a very strong role in cyber attacks in the future. Moments after a vulnerability becomes known, there will be attacks with AI. AI will also be used for automatic AI defenses. This is a rapid game now, and we will work and see what we can help out with in AI defense of cybersecurity. Sectra will be there at the front of this wave, but so are many other companies as well. It is a rapidly moving field. Good to remember, we had a board member once, G ündor Rentsch, he minted the phrase, "Where there is change, there is margin." The trick is you have to be faster than the other guys. Now we are quite a fast company, but this of course is a challenge to keep that speed up because now the world moves faster than before. Upcoming financial events is September 8. Next week, we have our annual general meeting. That will be a physical meeting in Linköping. Those of you who are shareholders are most welcome to come, or if you have announced your arrival, you have to pre-note to us that you are coming. Then we have the November 25, we have a six-monthly call. Again, I will remind you, these meetings or presentations are not for the sake of us. We knew this stuff beforehand, and we want it to be good for you and an effective way of transferring what you need to know. If you have any comments on the format of the presentations, please send an email to info.investor@sectra.com. We have changed the content quite a lot based on that input over the years. Now we open up for questions. You can either use raise your hand button in the Teams system, or you can use the chat function, and a moderator will read your questions here to us here. Then I leave the word to Helena, would we have heard anything coming in? Yes. Thank you, Torbjörn and Jessica, for your presentations. I actually will start with handing the word to Nikola Kalanoski at ABG. So you are welcome to unmute your phone and ask your questions. All right. Thank you very much. I hope you can hear me. Yes, we can. All right, great. Thanks for taking my questions. I will ask them one by one, if that is okay. The first one is on the reporting module. It sounds like you have quite significant interest in this module, but I am curious on one thing here. For your existing North American customers that are also potential future reporting module customers as well, what would you say is the primary advantage for purchasing your reporting module compared to purchasing from a competitor that does not provide PACS to them? It is faster. Radiologists of today or diagnosticians today are stressed. They have a very high workload. Every click is important. If you have to leave for another application to write or dictate a report or make a report, that takes time. We do it from inside the imaging window, which makes huge efficiencies. We can provide more intelligent reports because we can provide links to images, et cetera, for the clinicians to read. There is a speed-up and an efficiency boost for the diagnostic parties. Yeah, that sounds very reasonable. Then a bit curious on another topic, which is you have historically recruited quite significantly each year, but that pace has slowed a little bit somewhat recently in percentage terms. Now that AI tools are very helpful, should we see this as changing the balance between hiring new people versus spending more on AI tools that allow for higher productivity per head? Or should we think differently? Oh, that is a correct statement. AI will take over a lot of routine work. It will be a slow process. We cannot change this overnight, but gradually, AI will do a lot of boring stuff that we had people for before, and we will have a little less growth in people and growth in the cost for IT and AI. All right. Yep, that is also reasonable. Then a bit of a reporting question here. Just on the gross margin, it was down a little bit year-over-year. Is this primarily because of higher cloud costs that arise in relation to Sectra One Cloud revenues ramping up, or is there some different element to this from the Secure Communications segment as well? There are several explanations behind the margin development. Increasing cloud costs, yes, also increased external cost for migration, and we also had a slightly higher share of hardware versus Q1 last year. All right, perfect. That is all from me for now. Thank you very much. Thank you, Nikola. Then I will hand over the turn to Jakob Lembke at SEB. Yeah. Hi, and good morning. Hope you can hear me and see me as well. I will start with a question on the cloud recurring revenues in the quarter. Which I think, yeah, the quarter-on-quarter increase looks quite strong. If you can elaborate on what type of customers are driving that in the quarter. The main increase is for the large contracts in the U.K., U.S., and Canada, because these are contracts we have been working with and investing in for a long time, but are now beginning to go live. A larger portion of these customers are live. That, of course, when they begin to use it drives growth. Good. Also on the non-recurring revenues in Imaging IT, which also is quite strong, and I am wondering if you can elaborate on the year-on-year increase we have here in the quarter. How much of that is driven by license sales, and how much is driven by professional services and migration and so on? Well, you are spot on. It is driven by all of them. We have some license revenue in the quarter. But also, of course, in relation to these large go lives, we provide more migration and professional services, generating revenue. Okay, but were there any unusually large go lives of on-premise customers here in the quarter? We had, not unusual, but we don't have them every quarter, on-prem go lives with license revenue. It contributed, without being too detailed on the numbers, it contributed, but it's not only license revenue. In Scotland, it's a little special because Scotland, we're also responsible for some hardware, the clients. That's a lot of PCs that is included in our shipment that we forward to customers. So in Scotland, normally we don't do that, but in Britain, the contracts include some hardware as well. Even though the service side in the cloud, the clients are not. Okay, and just a follow-up on this. Given that you are in this intense period in implementing a lot of large contracts, I guess we should expect this sort of consulting hardware, migration, revenues, and so on to remain at quite high level here for the coming, let's say two years. We don't give that forecast. It changes quarter- by- quarter. It will not be significant. It will go up and down a little bit. Good. I'm also wondering if you can elaborate a bit on the reporting solution and, for example, if you're starting to win any customers in the U.S. We have advanced discussions with several customers. We have nothing published yet on any wins. Okay, good. I also have some questions on the large cloud contracts you're moving forward with. First of all, the large U.S. health system that you've talked about before, when do you expect to make any progress beyond the initial smaller region you have implemented for them? It's continuous progress. We're taking things live all the time. Good, then on Scotland, now that you are live with the first regions, do you have a sense of when it can be fully implemented with Scotland? Also Scotland is a very large project with very many health trusts. It will take one or two years more before we are completely live. Good. Then, just finally also on Québec, if you can say how many hospitals you are in right now. I don't know, but we started with two. We're now delivering many more. I don't know exactly the figure as of today, but it's becoming to get up in the teens, so to say. It's in progress, but far from completed. Maybe just a final question then also on AI, which you talked about here in the presentation. Just wondering, is cost for AI tools starting to become a meaningful cost item, and if so, also, where in the P&L do we see that? It is a growing cost, obviously. You will see it under other external expenses. That's where it will be a part, unless it's AI. The AI we use internally would be seen under other external expenses. Yeah, but sorry. From the looks of it then, it's not yet at a stage where it's a meaningful impact on the P&L, I guess. No. No, not yet. Who is speaking up? Yep. Good. That is all for me. Thank you. Thank you, Jakob. I am actually not seeing any more raised hands right now, so if you have a question, please raise your hand. While you are doing that, I will take some questions from Kristofer Liljeberg at DNB Carnegie that has been received by email. I will start with one on the orders. Could you please comment? They are, of course, lumpy, but how do you view the overall demand from new hospitals to sign enterprise imaging contracts? Do you see any trend shift in U.S. demands? Not in the U.S. I would say they are not affected by this trend. We see it in Europe because of the cloud problems with public clouds delivered by American companies, and that has kind of slowed everything down because that was what people thought they would do. All of a sudden, that is not as easy as people believed. So in Europe, we see some effects. In the U.S., there is no big change, at least not for the time being. How soon do you expect production and sales to ramp up? It's already ramped up. It affected first quarter, but the problems in the production is fixed, and we'll see that coming back to normal levels soon. Then we have two more financial detailed questions. What explains the somewhat weaker gross margin in Q1? The production ramp up in Secure Communications or larger hardware shipments in Imaging IT? If so, are those booked on the non-recurring sales line? All right. I repeat a little bit of what I said before. There are several factors impacting the gross margin, slightly higher share rate hardware is one of them, more external migration and cloud cost is the other. So that's more relating to the Imaging IT side of the business than the Secure Communications. Thank you. The next question is regarding EBIT margin. With 19% EBIT margin this quarter and Imaging IT improving margin 6 percentage points, do you think the overall group target is starting to look somewhat conservative? Would you need to accelerate costs even more next few years to deploy all new customers? I do not think we will have to increase the cost a lot, but it will be a lot of cost getting these big contracts live still. We do not comment on our goals and targets. That is a board decision. Thank you. Then I will see if we have any more questions. I cannot see any that has written questions, but I see that Jakob Lembke is raising his hand, so please go ahead. Yeah, just another one. Now that you have your first U.S. customer, or at least a larger U.S. customer that has upgraded from on-prem to cloud, do you see that the interest from other U.S. cloud or other U.S. on-premise customers to upgrade are increasing? Yes. It's increasing. It will be a long process, though. We have a lot of on-prem customers, and it's a large product, but it is increasing. People would like to go to cloud. It obviously works. We have not only done one, we have done a couple now, and we are learning. It's still a large product. It's a large change, but we don't see the reluctance that we see in Europe, in the U.S. and Canada. They are like, "Yes, we want to do this," because it saves them cost, it saves them space, and they can use their personnel money for medical people instead of IT people. Okay, good. Thank you. If you have some final questions, please raise your hand. It seems like it's not any further questions, so I leave the word to you, Torbjörn. All right. Thank you very much for joining our event. We hope to see a few of you next week at our annual meeting, and the rest of you we'll probably see in November then. Thank you very much for joining.